Qdenga dengue vaccine approved for age four and above

Health director-general Dr Muhammad Radzi Abu Hassan has announced the conditional approval of Takeda’s Qdenga dengue vaccine to those aged four and above.

In a statement by the Health Ministry, Radzi said the vaccine had been conditionally approved for registration after the Drug Control Authority (DCA) was satisfied with tests on its effectiveness, safety and product quality.

The statement did not...